Type I IFN Innate Immune Response to Adenovirus-mediated IFN-gamma Gene Transfer Contributes to the Regression of Cutaneous Lymphomas

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2007 Sep 8

PMID 17823660

Citations 22

Authors

Mirjana Urosevic

Kazuyasu Fujii

Bastien Calmels

Elisabeth Laine

Nikita Kobert

Bruce Acres

Reinhard Dummer

Affiliations

Soon will be listed here.

Abstract

The fact that adenoviral vectors activate innate immunity and induce type I IFNs has not been fully appreciated in the context of cancer gene therapy. Type I IFNs influence different aspects of human immune response and are believed to be crucial for efficient tumor rejection. We performed transcriptional profiling to characterize the response of cutaneous lymphomas to intralesional adenovirus-mediated IFN-gamma (Ad-IFN-gamma) gene transfer. Gene expression profiles of skin lesions obtained from 19 cutaneous lymphoma patients before and after treatment with Ad-IFN-gamma revealed a distinct gene signature consisting of IFN-gamma- and numerous IFN-alpha-inducible genes (type II- and type I-inducible genes, respectively). The type I IFN response appears to have been induced by the vector itself, and its complexity, in terms of immune activation, was potentiated by the IFN-gamma gene insert. Intralesional IFN-gamma expression together with the induction of a combined type I/II IFN response to Ad-IFN-gamma gene transfer seem to underlie the objective (measurable) clinical response of the treated lesions. Biological effects of type I IFNs seem to enhance those set in motion by the transgene, in our case IFN-gamma. This combination may prove to be of therapeutic importance in cytokine gene transfer using Ads.

Citing Articles

Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.

Tassi E, Bergamini A, Wignall J, SantAngelo M, Brunetto E, Balestrieri C Front Immunol. 2023; 14:1212444.

PMID: 37868997 PMC: 10585363. DOI: 10.3389/fimmu.2023.1212444.

Pan-cancer analysis of IFN-γ with possible immunotherapeutic significance: a verification of single-cell sequencing and bulk omics research.

Wei X, Ruan H, Zhang Y, Qin T, Zhang Y, Qin Y Front Immunol. 2023; 14:1202150.

PMID: 37646041 PMC: 10461559. DOI: 10.3389/fimmu.2023.1202150.

The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome.

Liu Z, Wu X, Hwang S, Liu J Ann Dermatol. 2021; 33(6):487-496.

PMID: 34858000 PMC: 8577908. DOI: 10.5021/ad.2021.33.6.487.

New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.

Fujii K Front Oncol. 2018; 8:198.

PMID: 29915722 PMC: 5994426. DOI: 10.3389/fonc.2018.00198.

A practical guide to the handling and administration of talimogene laherparepvec in Europe.

Harrington K, Michielin O, Malvehy J, Pezzani Gruter I, Grove L, Frauchiger A Onco Targets Ther. 2017; 10:3867-3880.

PMID: 28814886 PMC: 5546812. DOI: 10.2147/OTT.S133699.

References

Dunn G, Koebel C, Schreiber R . Interferons, immunity and cancer immunoediting. Nat Rev Immunol. 2006; 6(11):836-48. DOI: 10.1038/nri1961. View

Cerullo V, Seiler M, Mane V, Brunetti-Pierri N, Clarke C, Bertin T . Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol Ther. 2007; 15(2):378-85. DOI: 10.1038/sj.mt.6300031. View

Garcia-Sastre A, Biron C . Type 1 interferons and the virus-host relationship: a lesson in détente . Science. 2006; 312(5775):879-82. DOI: 10.1126/science.1125676. View

Yoshimura A . Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 2006; 97(6):439-47. PMC: 11159428. DOI: 10.1111/j.1349-7006.2006.00197.x. View

Huarte E, Larrea E, Hernandez-Alcoceba R, Alfaro C, Murillo O, Arina A . Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication. Mol Ther. 2006; 14(1):129-38. DOI: 10.1016/j.ymthe.2006.02.015. View

Yang G, Xu Y, Chen X, Hu G . IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene. 2006; 26(4):594-603. DOI: 10.1038/sj.onc.1209807. View

Hartman Z, Kiang A, Everett R, Serra D, Yang X, Clay T . Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. J Virol. 2006; 81(4):1796-812. PMC: 1797572. DOI: 10.1128/JVI.01936-06. View

Hartman Z, Black E, Amalfitano A . Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells. Virology. 2006; 358(2):357-72. DOI: 10.1016/j.virol.2006.08.041. View

Zhu J, Huang X, Yang Y . Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J Virol. 2007; 81(7):3170-80. PMC: 1866082. DOI: 10.1128/JVI.02192-06. View

10.

Tracey L, Villuendas R, Ortiz P, Dopazo A, Spiteri I, Lombardia L . Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am J Pathol. 2002; 161(5):1825-37. PMC: 1850769. DOI: 10.1016/s0002-9440(10)64459-8. View

11.

Platanias L . Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005; 5(5):375-86. DOI: 10.1038/nri1604. View

12.

Scibetta A, Copier J, Barrett A, Chaplin T, Taylor-Papadimitriou J . Gene expression changes induced by a recombinant E1-/E3- adenovirus type 5 vector in human mammary epithelial cells. Intervirology. 2005; 48(6):350-61. DOI: 10.1159/000086062. View

13.

Zhao C, Denison C, Huibregtse J, Gygi S, Krug R . Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A. 2005; 102(29):10200-5. PMC: 1177427. DOI: 10.1073/pnas.0504754102. View

14.

Urosevic M, Dummer R, Conrad C, Beyeler M, Laine E, Burg G . Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. J Natl Cancer Inst. 2005; 97(15):1143-53. DOI: 10.1093/jnci/dji207. View

15.

Urosevic M, Conrad C, Kamarashev J, Asagoe K, Cozzio A, Burg G . CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum Pathol. 2005; 36(9):1020-4. DOI: 10.1016/j.humpath.2005.07.002. View

16.

Hensley S, Giles-Davis W, McCoy K, Weninger W, Ertl H . Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors. J Immunol. 2005; 175(9):6032-41. DOI: 10.4049/jimmunol.175.9.6032. View

17.

Platanias L, Fish E . Signaling pathways activated by interferons. Exp Hematol. 1999; 27(11):1583-92. DOI: 10.1016/s0301-472x(99)00109-5. View

18.

Brown M, Grundy W, Lin D, Cristianini N, Sugnet C, Furey T . Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci U S A. 2000; 97(1):262-7. PMC: 26651. DOI: 10.1073/pnas.97.1.262. View

19.

Geutskens S, van der Eb M, Plomp A, Jonges L, Cramer S, Ensink N . Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells. Gene Ther. 2000; 7(16):1410-6. DOI: 10.1038/sj.gt.3301251. View

20.

Dummer R, Dobbeling U, Geertsen R, Willers J, Burg G, Pavlovic J . Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication. Blood. 2001; 97(2):523-7. DOI: 10.1182/blood.v97.2.523. View